Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Eastroc Beverage / Equity Capital Markets

<ul>
<li>Eastroc Beverage Group launched its Hongkong IPO aiming to raise up to HK$ 10.1B. The company plans to sell 40.9M shares at HK$248 per share.</li>
<li>Eastroc Beverage is a functional beverage company in China, with primary focus on energy beverages and sports beverages. Company enjoyed 26.3% market share in 2024 (in terms of sales volume).</li>
<li>We would recommend the investors to subscribe to the issue backed by strong growth visibility and secular demand pure play.</li>
</ul>


Eastroc Beverage Group launched its Hongkong IPO aiming to raise up to HK$ 10.1B. The company plans to sell 40.9M shares at HK$248 per share.
Eastroc Beverage is a functional beverage company in China, with primary focus on energy beverages and sports beverages. Company enjoyed 26.3% market share in 2024 (in terms of sales volume).
We would recommend the investors to subscribe to the issue backed by strong growth visibility and secular demand pure play.


Eastroc Beverage A/H Listing: Growth Visibility Makes It Functional for Investors to Gulp It Down